TEXT-EXTRACT 2 filename2.txt January 6, 2020 Gregory K. Chow Chief Financial Officer Aptose Biosciences Inc. 251 Consumers Road, Suite 1105 Toronto, Ontario, Canada M2J 4R3 Re: Aptose Biosciences Inc. Registration Statement on Form S-3 Filed December 27, 2019 File No. 333-235730 Dear Mr. Chow: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Daniel M. Miller, Esq.